Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-02-25 @ 8:50 PM
Study NCT ID:
NCT01967095
Status:
COMPLETED
Last Update Posted:
2018-11-13
First Post:
2013-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization: